Skip to content

Joint research on treatments for heart diseases using MSC-CM

Multi-Institutional Joint Research on Treatments for Heart Diseases Using Human-Derived Mesenchymal Stem Cell Conditioned Medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051250143
Enrollment
80
Registered
2025-10-27
Start date
2025-10-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart diseases Heart diseases, Heart failure, Myocardial infarction

Interventions

None listed

Sponsors

Maeda Shingo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who did not experience satisfactory treatment effects with standard therapy. 2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate. Inclusion criteria for patients are as follows: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals with serum BNP levels of equal to or higher than 40 pg/mL. 4. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 5. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals who meet any of the following conditions will be excluded: 1. Individuals who have a history of or suspected dementia. 2. Individuals who use narcotics or stimulants. 3. Individuals who are pregnant. 4. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

MeasureTime frame
- Condition of the patient - Frequency of hospitalization - Cardiac ultrasound examination - Carotid ultrasound examination - Chest X-ray - Electro-cardiogram - ABI test - Serum BNP levels - NYHA cardiac function classification and ACCF/AHA heart failure stage classification - Grip strength measurement

Contacts

Public ContactShingo Maeda

Azabu-Juban TT Heart Clinic

smaeda@ttheart.jp+81-3-6453-7123

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026